- Home
- KNSA vs NAVI Comparison
KNSA vs NAVI Comparison
Compare KNSA & NAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- NAVI
- Stock Information
- Founded
- KNSA 2015
- NAVI 1973
- Country
- KNSA United Kingdom
- NAVI United States
- Employees
- KNSA N/A
- NAVI N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- NAVI Investment Bankers/Brokers/Service
- Sector
- KNSA Health Care
- NAVI Finance
- Exchange
- KNSA Nasdaq
- NAVI Nasdaq
- Market Cap
- KNSA 1.3B
- NAVI 1.4B
- IPO Year
- KNSA 2018
- NAVI N/A
- Fundamental
- Price
- KNSA $18.73
- NAVI $14.26
- Analyst Decision
- KNSA Strong Buy
- NAVI Hold
- Analyst Count
- KNSA 5
- NAVI 8
- Target Price
- KNSA $36.60
- NAVI $14.56
- AVG Volume (30 Days)
- KNSA 469.7K
- NAVI 960.6K
- Earning Date
- KNSA 02-26-2025
- NAVI 01-29-2025
- Dividend Yield
- KNSA N/A
- NAVI 4.48%
- EPS Growth
- KNSA N/A
- NAVI N/A
- EPS
- KNSA N/A
- NAVI 0.70
- Revenue
- KNSA $384,098,000.00
- NAVI $1,036,000,000.00
- Revenue This Year
- KNSA $60.05
- NAVI N/A
- Revenue Next Year
- KNSA $36.74
- NAVI $7.80
- P/E Ratio
- KNSA N/A
- NAVI $19.97
- Revenue Growth
- KNSA 54.41
- NAVI N/A
- 52 Week Low
- KNSA $16.56
- NAVI $12.73
- 52 Week High
- KNSA $28.15
- NAVI $18.37
- Technical
- Relative Strength Index (RSI)
- KNSA 38.56
- NAVI 57.21
- Support Level
- KNSA $18.27
- NAVI $12.73
- Resistance Level
- KNSA $19.05
- NAVI $13.66
- Average True Range (ATR)
- KNSA 0.61
- NAVI 0.33
- MACD
- KNSA -0.05
- NAVI 0.17
- Stochastic Oscillator
- KNSA 34.42
- NAVI 87.43
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About NAVI Navient Corporation
Navient Corp provides technology-enabled education finance and business processing solutions that simplify complex programs and help millions of people achieve success. It operates business in three segments: Federal Education Loans, Consumer Lending and Business Processing.